Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease

Unplanned interim analysis (n=2289) did not show a difference in the incidence of death during 1 to 4 years of follow-up between the patients with peripheral artery disease who received treatment with paclitaxel-coated or uncoated endovascular devices groups.

Source:

New England Journal of Medicine